Compared to the previous generation, CAPILLARYS 3 TERA offers the enhanced throughput of a 12 capillary system and can be turned into a MC configuration, aggregating 1 to 3 CAPILLARYS 3 TERA to a tube loader (528 positions).
The CAPILLARYS 3 TERA offers a broad assay menu in myeloma, diabetes, hemoglobinopathies and chronic alcohol abuse.
The CAPILLARYS 3 TERA shares the same reagents and consumables as the other CAPILLARYS 3 instruments, allowing the lab to adopt the most relevant platforms, mixing CAPILLARYS 3 OCTA, TERA and TERA MC configurations to match exactly the needs of their organization.
CAPILLARYS 3 TERA instruments can evolve into a workcell configuration. Linked to Sebia’s MC loader, 1 to 3 CAPILLARYS 3 TERA will deliver a very high throughput for a single or multiple electrophoresis capillary techniques.
4 open positions for main reagents, temperature-controlled section for secondary reagent (antisera), automated reagent identification, change buffer without interrupting the testing.
Delivered with each Sebia’s instrument, the PHORESIS software allows laboratories to manage the instrument results providing a very flexible solution.
Sample types: whole blood, urine, serum
With 12 capillaries, the CAPILLARYS 3 TERA can produce large amount of results with a low hands-on-time. The instrument has a related loading capacity of 15 racks (120 tubes).
Throughput (tests/hour)*
PROTEIN(E) 6 (serum) 99
PROTEIN(E) 6 (urine) 97
IMMUNOTYPING (serum or urine) 11
Hb A1c 63
HEMOGLOBIN(E) 65
CDT 73
* Using Software version 9.30
High throughput Serum Protein Electrophoresis with high resolution results.
High throughput Urine Protein Electrophoresis, with high resolution results.
Fully automated monoclonal proteins identification by Capillarys electrophoresis.
The high-resolution method for hemoglobin disorders screening.
The most reliable chronic alcohol abuse marker.
Understand in 2 minutes how capillary electrophoresis works, and why it gives such high and clear resolution in lab testing.
Understand your needs and constraints to provide you with the most suitable and integrated solution.
Interview between Sebia and M. Jean Deenmamode, CDT IFCC Working Group Chair
IFCC Standardisation of the Sebia CDT measurement on CAPILLARYS 3 TERA.
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Educational Webinar with Dr. Julien GUILLEMAUD
CSCC Niagara Falls 2022
Sebia booth: #300
Educational Webinar with Dr. Jack Maggiore from Loyola University Medical Center in Chicago, IL
Educational Webinar with Jason EYRE
CDT is a sensitive and specific marker of chronic alcohol abuse, used in several contexts and notably including forensic settings, industries, clinical applications.
Educational Webinar with Dr. Barbara De la Salle
Educational Webinar with Dr. Barbara De la Salle
This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.
The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers.
Hemoglobin C, D Punjab, E or S trait can interfere with hemoglobin A1c (HbA1c) results depending on the method of analysis used. Therefore, it is important to know the limitations of the method used for HbA1c determination.
Article from Jean Deenmamode, IFCC CDT working group chair in CLI magazine.
IFCC CDT-Working Group standardized the CDT measurement.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.